A Phase II Study of Reduced Intensity Allogeneic Bone Marrow Transplant for the Treatment of Myelodysplastic Syndromes.
Phase of Trial: Phase II
Latest Information Update: 18 Jan 2015
At a glance
- Drugs Pentostatin (Primary) ; Ciclosporin; Methotrexate; Methoxsalen; Mycophenolate mofetil
- Indications Chronic myelomonocytic leukaemia; Graft-versus-host disease; Myelodysplastic syndromes
- Focus Therapeutic Use
- 29 Sep 2009 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
- 19 Nov 2005 New trial record.